Replies to post #286421 on Amarin Corp Plc (AMRN)

[mrmainstreet]

It's my own fault. With an average of just over $3 I should have sold over $20, but got greedy dreaming of $40 and thinking we had overcome every risk event.

The patent case was not on my radar as such a potential killer, so I failed in my DD as well.

I'm still up but it's disappointing that a new drug such as Vascepa is languishing 2 years after showing 25% RRR. It's really a shame.

I thought we'd be part of a BO in 2019 which drove my decision to hold.